Icu Medical Inc/de Form 4 insider transactions

Daniel Woolson, VP, GM-Infusion Capital of Icu Medical Inc/De, sold 5,417 shares of common stock on August 13, 2026 for $181.33 per share.

Ben Sousa, Chief Information Officer of Icu Medical Inc/De, sold 2,250 shares of common stock on August 12, 2026 for $178.32 per share.

Christian B. Voigtlander, Chief Operating Officer of Icu Medical Inc/De, sold 8,929 shares of common stock on August 11, 2026 for $182.93 per share.

Elisha W Finney, a Director of Icu Medical Inc/De, sold 378 shares of common stock on August 11, 2026 for $182.48 per share.

ICU Medical President Daniel Woolson sold 2,123 shares of common stock on May 22, 2026.

Virginia Ruth Sanzone, VP and General Counsel of ICU Medical, Inc., reported a sale of 2,447 shares of common stock on May 14, 2026.

Director Kolleen T. Kennedy acquired 1,254 shares of ICU Medical common stock through the vesting of restricted stock units.

Director Laurie Hernandez acquired 1,254 shares of ICU Medical common stock through the vesting of restricted stock units.

Director Elisha W. Finney acquired 1,254 shares of ICU Medical common stock via restricted stock unit vesting and was granted 1,475 new units.

Director Donald Abbey acquired 1,254 shares of ICU Medical common stock through the vesting of restricted stock units.

ICU Medical Director David F. Hoffmeister acquired 1,254 shares of common stock through the vesting of restricted stock units.

Director David C. Greenberg exercised stock options and sold shares of ICU Medical, Inc. (ICUI) in a series of transactions.

ICU Medical Director Donald Abbey reported a transfer of 704 common shares pursuant to a domestic relations order.

ICU Medical's Chief Operating Officer, Christian B. Voigtlander, reported the acquisition and subsequent tax-related disposal of common stock derived from performance-based and restricted stock units.

Daniel Woolson, VP at ICU Medical, converted performance-based restricted stock units into common stock and subsequently sold a portion to cover tax obligations.

ICU Medical's Chief Information Officer, Ben Sousa, converted 1,300 Restricted Stock Units into common stock and subsequently sold 718 shares to cover tax obligations on March 15, 2026.

ICU Medical's VP, General Counsel, Virginia Sanzone, reported the vesting of performance-based and restricted stock units, leading to an increase in her direct common stock ownership.

ICU Medical's Chairman and CEO, Vivek Jain, reported the vesting and settlement of performance-based and restricted stock units, along with related tax withholdings, as part of his compensation.

ICU Medical's Chief Financial Officer, Brian Bonnell, reported the exercise and settlement of performance-based and restricted stock units, along with associated tax withholdings.

ICU Medical's VP, GM-Infusion Capital, Daniel Woolson, sold 2,897 shares of common stock at $152.3522 per share.

ICU Medical Director Elisha W Finney exercised stock options and subsequently sold 1,285 shares of common stock.

ICU Medical's VP, General Counsel, Virginia Sanzone, sold 930 shares of common stock for $142.345 per share.

ICU Medical's Chairman and CEO, Vivek Jain, gifted 63,641 shares of common stock to family trusts on September 12, 2025.

ICU Medical Director David C. Greenberg acquired 1,200 shares of common stock through open market purchases on August 27, 2025.

ICU Medical's Chairman and CEO, Vivek Jain, significantly increased his direct ownership in the company through two substantial common stock purchases totaling over $2.47 million.

Virginia Sanzone, VP and General Counsel of ICU Medical Inc., has filed a Form 4 indicating a future sale of 700 shares of common stock on May 30, 2025, at a price of $133.6244 per share, under a Rule 10b5-1 plan.

ICU Medical's Chief Operating Officer, Christian B. Voigtlander, engaged in a series of transactions involving the exercise of stock options and subsequent sale of common stock on May 27 and May 28, 2025, under a Rule 10b5-1 trading plan.

ICU Medical's Chief Operating Officer, Christian B. Voigtlander, exercised stock options and subsequently sold a portion of the acquired shares over two days in May 2025.

Christian Voigtlander, COO of ICU Medical, exercised stock options and sold shares on May 20 and 21, 2025.

Director Elisha W. Finney of ICU Medical Inc. sold 600 shares of common stock at a price of $138.9209 on May 19, 2025.